HUMAN MICROBIOME MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)
Human Microbiome Market Analysis:
The human microbiome has garnered considerable attention in recent times due to its association with various respiratory diseases and immunity. The gut microbiome, in particular, has been linked to good immunity. Researchers have reported that variations in the number of microorganisms, such as actinobacteria, firmicute, and Bacteroidetes, can lead to the development of lung, respiratory, and other disorders. For example, Persephone Biosciences Inc. began developing an immune-boosting microbiome therapeutic in April 2020 to help prevent and fight the novel coronavirus (SARS-CoV-2) and a potential stool-based diagnostic test designed to help predict which patients are at the highest risk for developing severe complications and mortality after suffering COVID-19. Thus, increasing research studies on the microbiome are the key drivers affirming the growth of this market. The pandemic has created awareness about microbiota therapeutics and diagnosis, and the market is expected to follow the same trend even during the post-pandemic period.
Other key factors propelling the growth of this market are the increasing burden of lifestyle-related diseases and the growing geriatric population. For instance, according to the International Diabetes Federation 2021 statistics, there are 52.7 million people aged 20–79 years in Europe with diabetes, and this number is expected to reach 69 million by the year 2045. Increased gut microbial diversity, along with specifically more butyrate-producing bacteria, benefitting insulin resistance and risk of type 2 diabetes, increases the burden of lifestyle diseases such as diabetes, and is expected to drive the growth of the market over the forecast period.
Increasing funding initiatives and government programs to support this research are high-impact rendering drivers anticipated to foster market growth. For example, according to the National Institute of Health, in May 2022, the Federal Government of the United States incurred USD 864 million on research and development of the microbiome in 2021 and is expected to spend USD 903 million in 2022. Such investment by the government is propelling the growth of the market over the forecast period. However, a lack of comprehensive research and stringent government regulations are likely to limit the market growth over the forecast period.
Get the free sample report of the Human Microbiome Market.
Comments
Post a Comment